AGE RELATED MACULOPATHY--DRUSEN BIOGENESIS
年龄相关性黄斑病变--玻璃疣的生物发生
基本信息
- 批准号:2459185
- 负责人:
- 金额:$ 19.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): AMD is characterized
by the progressive loss of vision in the central visual field
attributable to atrophic, exudative and/or hemorrhagic changes in the
macula. No pharmacologic treatment has been shown to be effective in
preventing, arresting, or reversing loss of vision associated with AMD.
The proposed research has focused primarily on drusen, which are
accumulations of extracellular material that develop between the retinal
pigment epithelium (RPE) and its blood supply, the choriocapillaris.
Relatively little is known about the origin or the composition of
drusen, even though drusen deposits are considered widely as a
significant risk factor for the development of both atrophic and
exudative AMD. Preliminary studies of drusen composition have led to
the identification of specific drusen-associated molecules (DRAMs), many
of which are circulating plasma proteins and known participants in the
processes of fibrinolysis, thrombosis, inflammation, and/or the immune
response. In this proposal, the emphasis is on drusen biogenesis, the
identification of the ligands for DRAMs in the RPE-choroid in the
transcellular pathways involved in DRAM deposition. The experimental
cell line in this as well as the two companion proposals are designed
to clarify the relationship between ocular drusen, related choroidal
abnormalities, and the subsequent development of atrophic AMD. In so
doing, the applicants hope to establish a conceptual framework for
pursuing additional basic and clinical research into the causes and
prevention of AMD.
描述(改编自申请人的摘要):AMD的特征
由中央视野进行性视力丧失所致
可归因于脑部的萎缩、渗出和/或出血性改变
黑斑。没有任何药物治疗被证明是有效的
预防、阻止或扭转与老年性黄斑变性相关的视力丧失。
拟议的研究主要集中在干酪,它们是
在视网膜之间形成的细胞外物质的堆积
色素上皮(RPE)及其血液供应,脉络膜毛细血管。
人们对它的起源或成分知之甚少。
绿泥石,尽管绿泥石矿床被广泛认为是一种
萎缩性和慢性萎缩性心脏病发生的重要危险因素
渗出性AMD。对软骨膜成分的初步研究导致了
鉴定特定的干酪蛋白相关分子(DRAM),许多
其中包括循环中的血浆蛋白和已知的
纤溶、血栓、炎症和/或免疫过程
回应。在这项提案中,重点是干酪生物发生,即
视网膜色素上皮-脉络膜中DRAMs配体的鉴定
参与DRAM沉积的跨细胞通路。实验性的
在此设计了细胞系以及两个配套的方案
阐明眼部玻璃体与脉络膜的关系
异常,以及随后萎缩性AMD的发展。在苏中
这样做,申请者希望建立一个概念性的框架
正在进行更多的基础和临床研究,以了解病因和
AMD的预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DON H ANDERSON其他文献
DON H ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DON H ANDERSON', 18)}}的其他基金
AGE RELATED MACULOPATHY--DRUSEN BIOGENESIS
年龄相关性黄斑病变--玻璃疣的生物发生
- 批准号:
2165830 - 财政年份:1996
- 资助金额:
$ 19.28万 - 项目类别:
AGE RELATED MACULOPATHY--DRUSEN BIOGENESIS
年龄相关性黄斑病变--玻璃疣的生物发生
- 批准号:
2711188 - 财政年份:1996
- 资助金额:
$ 19.28万 - 项目类别:
DEGENERATION AND REGENERATION IN THE MAMMALIAN RETINA
哺乳动物视网膜的退化和再生
- 批准号:
2158338 - 财政年份:1977
- 资助金额:
$ 19.28万 - 项目类别:
RELATIONSHIP OF MAMMALIAN CONES TO PIGMENT EPIHELIUM
哺乳动物视锥细胞与上皮色素的关系
- 批准号:
3256490 - 财政年份:1977
- 资助金额:
$ 19.28万 - 项目类别:
DEGENERATION AND REGENERATION IN THE MAMMALIAN RETINA
哺乳动物视网膜的退化和再生
- 批准号:
3256493 - 财政年份:1977
- 资助金额:
$ 19.28万 - 项目类别:
RELATIONSHIP OF MAMMALIAN CONES TO PIGMENT EPIHELIUM
哺乳动物视锥细胞与上皮色素的关系
- 批准号:
3256485 - 财政年份:1977
- 资助金额:
$ 19.28万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 19.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




